Hamlet Minasvand
Optometry · Glendale, CANPI 1982885273
Payments from drug & device makers
What this record shows
Among optometry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
How this compares
$0 in reported general payments places this provider in the 95th percentile of 99 optometry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 41 | $12,564 |
| RestasisCyclosporine | 12 | $7,652 |
Paid to pharmacies, not to this prescriber.
Other optometry in Glendale
- Betty Lee-VillanuevaGlendale$0
- John MielkeGlendale$0
- Sophia HsiaGlendale$0
- Andrawis ZadaSan Mateo$4K
- Sarah KwokSanta Clara$1K
- Justin OgoyRedlands$1K
- Edgar AguilarEl Centro$550
- Mark ParkDelano$0
- Kevin TalagaSacramento$0
- Alexis WinnCupertino$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.